Bill Letendre, PCCA's Vice President of Pharmacy Management Systems (CPMS) discusses how building partnerships with other surrounding businesses in communities can be a powerful marketing tool for compounding pharmacies.

Members of PCCA's Clinical Services and PCCA Science teams provide a review of some of the research into the morbidity, mortality and pathogenicity of SARS-CoV-2. The information gathered is based on the best scientific evidence currently available regarding potential treatments. They also take the time to explore some potential non-prescription and prescription options based on their research.

Gus Bassani, PCCA's Chief Scientific Officer, discusses the important nuances compounders should know when dealing with brand name products versus their generic counterparts and FDA's position on buying from quality raw material providers.

Jane Jones discusses "maskne", a new medical condition becoming more pervasive due to the repetitive use of facial masks. Jane talks about prevention and treatments that can potentially alleviate symptoms using compounded medications.

Deborah Clark of PCCA's Clinical Services team discusses the key factors and common issues in equine compounding, and how veterinary compounders can learn from her experience.

Sara Hover of PCCA's Clinical Services discusses medical treatment and management options for pharmacists helping patients whose health is challenged by polycystic ovary syndrome (PCOS).

Congratulations to Ginny Isbell and Terry Wingo for being our September Profile in Personalized Medicine. These profiles celebrate members of the PCCA family who have proven to be champions of pharmacy compounding by providing the highest quality of service to their patients.